Literature DB >> 25553687

Combined use of borneol or menthol with labrasol promotes penetration of baicalin through rabbit cornea in vitro.

Lei Huang1, Jianhai Bai1, Hongbin Yang1, Jingjing Liu1, Hao Cui1.   

Abstract

The permeability of most drugs through the eyes is very limited, so finding safe and effective penetration enhancers is of high importance in current ophthalmology research. In this paper, we use a new approach that integrates Chinese and Western medicine to improve the corneal permeability of baicalin, a water- and fat-insoluble target drug, in vitro. Rabbits were divided into three groups. The first group was dosed with borneol (0.05%, 0.1%). menthol (0.1%, 0.2%), or Labrasol (1%, 2%) individually, the second was dosed with a combination of Labrasol with either borneol or menthol, and the third group received a control treatment. Compared with the control treatment, borneol, menthol, or Labrasol alone clearly improved the permeability of baicalin in vitro. Furthermore, the penetrating effects were significantly increased by combining the application of Labrasol with menthol or borneol. Among the various combined penetration enhancers, 0.1% borneol with 2% Labrasol achieved the best apparent permeability, approximately 16.35 times that of the control. Additionally, the calculation of corneal hydration level and the Draize test demonstrated the safety of these penetration enhancers to the rabbit corneas in vivo. This study confirms that the combined use of borneol or menthol, compounds both derived from Chinese herbs, with Labrasol can improve the corneal permeability of water- and fat-insoluble drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25553687

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  7 in total

Review 1.  Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers.

Authors:  Madhur Kulkarni; Niserga Sawant; Anjali Kolapkar; Aishwarya Huprikar; Namita Desai
Journal:  AAPS PharmSciTech       Date:  2021-04-28       Impact factor: 3.246

2.  Study of penetration mechanism of labrasol on rabbit cornea by Ussing chamber, RT-PCR assay, Western blot and immunohistochemistry.

Authors:  Pan Guo; Nan Li; Lili Fan; Jun Lu; Boying Liu; Bing Zhang; Yumei Wu; Zhidong Liu; Jiawei Li; Jiaxin Pi; Dongli Qi
Journal:  Asian J Pharm Sci       Date:  2018-06-15       Impact factor: 6.598

Review 3.  Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.

Authors:  Jinxiu Li; Qian Xie; Rong Ma; Yong Li; Jianmei Yuan; Mihong Ren; Hongyan Li; Jiajun Wang; Danni Lu; Zhuo Xu; Jian Wang
Journal:  Front Med (Lausanne)       Date:  2021-11-25

4.  d-Borneol enhances cisplatin sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis in non-small cell lung cancer cells and a murine xenograft model.

Authors:  Jinxiu Li; Jianmei Yuan; Yong Li; Jian Wang; Daoyin Gong; Qian Xie; Rong Ma; Jiajun Wang; Mihong Ren; Danni Lu; Zhuo Xu
Journal:  Cell Mol Biol Lett       Date:  2022-07-26       Impact factor: 8.702

5.  Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol.

Authors:  Lin Zhang; Shou-Ying Du; Yang Lu; Chang Liu; Zhi-Hao Tian; Chang Yang; Hui-Chao Wu; Zhen Wang
Journal:  Drug Des Devel Ther       Date:  2016-07-08       Impact factor: 4.162

6.  TRPM8-regulated calcium mobilization plays a critical role in synergistic chemosensitization of Borneol on Doxorubicin.

Authors:  Haoqiang Lai; Chang Liu; Liyuan Hou; Wenwei Lin; Tianfeng Chen; An Hong
Journal:  Theranostics       Date:  2020-08-13       Impact factor: 11.556

7.  Physicochemical Characterization and Simulation of the Solid-Liquid Equilibrium Phase Diagram of Terpene-Based Eutectic Solvent Systems.

Authors:  Maha M Abdallah; Simon Müller; Andrés González de Castilla; Pavel Gurikov; Ana A Matias; Maria do Rosário Bronze; Naiara Fernández
Journal:  Molecules       Date:  2021-03-23       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.